US › Healthcare

Hyperfine Inc (HYPR)

US · Healthcare · Medical Devices

$1.02+3.95%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$3.9M
Revenue YoY
+82.6%
Net profit
$-8.6M
Profit YoY
+8.4%
EPS
$-0.09
EPS estimate
$-0.11
Net margin
-220.9%

EPS came in at -0.09 against a street estimate of -0.11 — a beat of 19.7%.

Key statistics

Market cap
$92.9M
Forward P/E
0.0
P/B
2.72
Book value
$0.35
EPS (TTM)
$-0.40
52-week high
$2.22
52-week low
$0.85
50-day MA
$1.29
200-day MA
$1.22
Beta
1.40

Analyst view

Analysts rate Hyperfine Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $2.17.

Shareholding

Insiders
4.81%
Institutions
15.53%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC3.48%
Fosun International Ltd1.75%
Catalio Capital Management, LP1.33%
Sio Capital Management, LLC1.01%
Geode Capital Management, LLC0.96%
Alphabet Inc0.91%
Renaissance Technologies Corp0.74%
BlackRock Inc0.58%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Hyperfine Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.